Sofosbuvir Enrolling by Invitation Phase 3 Trials for Hepatitis C Virus Infection / Hepatitis C Virus (HCV) Infection Treatment

Enrolling by InvitationTreatment3 IdentifierTitleDrugs
NCT02939989A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study